logo

Last Update

This profile was last updated on 1/25/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Oliver Keil?

Oliver Keil

Head of CMC

Silence Therapeutics plc

HQ Phone:  +44 20 3700 9711

Direct Phone: +49 ** ********direct phone

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Silence Therapeutics plc

1 Lyric Square

London, Greater London,W6 0NB

United Kingdom

Company Description

Silence Therapeutics plc (AIM: SLN) is a leading biotechnology company dedicated to the discovery, development and delivery of targeted, systemic RNA interference (RNAi) therapeutics for the treatment of serious diseases. Silence offers one of the most compreh...more

Find other employees at this company (70)

Background Information

Employment History

G.O.T. Therapeutics


Affiliations

Medicinal

Post Doctoral Fellow At the Faculty


University of Duesseldorf

Post Doctoral Fellow At the Medicinal Faculty


Education

Ph.D.

Department of Organic Chemistry

University of Wuppertal


Web References(2 Total References)


www.atugen.com

Oliver KeilDr. Oliver Keil, Director Lipid ChemistryPrior to joining Atugen in 2003 Dr. Keil worked for G.O.T. Therapeutics from 2000 until 2003.Dr. Keil was a Post Doctoral Fellow at the Medicinal Faculty of the University of Duesseldorf.He obtained his Ph.D. in the Department of Organic Chemistry at the University of Wuppertal in 1998.His thesis focused on the synthesis of novel cationic lipids for the gene transfer into eukaryotic cells.Dr. Keil has extensive experience in organic and medicinal chemistry.He published numerous research articles and filed several patent applications.


www.silence-therapeutics.com [cached]

Dr. Oliver Keil, Director Lipid Chemistry
Prior to joining Atugen in 2003 Dr. Keil worked for G.O.T. Therapeutics from 2000 until 2003. Dr. Keil was a Post Doctoral Fellow at the Medicinal Faculty of the University of Duesseldorf. He obtained his Ph.D. in the Department of Organic Chemistry at the University of Wuppertal in 1998. His thesis focused on the synthesis of novel cationic lipids for the gene transfer into eukaryotic cells. Dr. Keil has extensive experience in organic and medicinal chemistry. He published numerous research articles and filed several patent applications.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory